EAN 2026 | The emerging role of AI in the diagnosis and management of multiple sclerosis

Celia Oreja-Guevara, MD, PhD, University Hospital San Carlos, Madrid, Spain, outlines how artificial intelligence (AI) could be used to improve the diagnosis and management of multiple sclerosis (MS). Dr Oreja-Guevara outlines the potential applications in MRI analysis, as well as in optical coherence tomography to differentiate between MS, neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD). This interview took place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.